Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gabapentin and Dexmedetomidine for Post-Mastectomy Pain
NCT04976374Unknown
- Sponsor
- National Cancer Institute
- Start
- May 2021
- Primary completion
- Nov 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of dexmedetomidine and gabapentin in postoperative pain, sponsored by National Cancer Institute. Primary endpoint: Postoperative morphine consumption at 24 hours. Status: unknown.
02
Drugs
dexmedetomidinegabapentin
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT04976374.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04976374.